Published in Clin Gastroenterol Hepatol on June 01, 2004
Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology (2014) 1.58
Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C. Liver Transpl (2012) 1.54
Race and mortality after acute renal failure. J Am Soc Nephrol (2007) 1.35
Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C. Clin Gastroenterol Hepatol (2008) 1.19
Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women. Hepatology (2012) 0.91
Hepatitis B and C in African Americans: current status and continued challenges. Clin Gastroenterol Hepatol (2013) 0.87
Demographics of a large cohort of urban chronic hepatitis C patients. Hepatol Int (2008) 0.85
Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeutics. Ann Hepatol (2015) 0.81
Ethnicity and hepatitis C virus infection. Clin Gastroenterol Hepatol (2004) 0.78
Genes transactivated by hepatitis C virus core protein, a microarray assay. World J Gastroenterol (2005) 0.77
Altered of apoptotic markers of both extrinsic and intrinsic pathways induced by hepatitis C virus infection in peripheral blood mononuclear cells. Virol J (2012) 0.77
Racial differences in the association between adiposity measures and the risk of hepatitis C-related liver disease. J Clin Gastroenterol (2012) 0.77
Effect of Treatment for CHC on Liver Disease Progression and Hepatocellular Carcinoma Development in African Americans. J Clin Transl Hepatol (2015) 0.75
End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection. J Viral Hepat (2012) 0.75
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet (2013) 6.19
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology (2006) 4.90
Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1. Hepatology (2004) 3.47
Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection. J Infect Dis (2009) 2.53
Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res (2007) 2.50
Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol (2005) 2.47
Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology (2007) 2.25
Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys (2004) 2.11
Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology (2002) 2.10
Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. Hepatology (2006) 2.08
Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway. Hepatology (2010) 1.86
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology (2005) 1.81
An assessment of statin safety by hepatologists. Am J Cardiol (2006) 1.78
Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C. Gastroenterology (2010) 1.67
Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Res (2008) 1.67
Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. Transplantation (2009) 1.66
Early diagnosis of breast cancer by hair diffraction. Int J Cancer (2005) 1.62
Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. Am J Pathol (2002) 1.58
Quantitation of pretreatment serum interferon-γ-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response. Hepatology (2011) 1.53
The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol (2005) 1.49
leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem (2007) 1.48
Shanthi V. Sitaraman, MD, PhD: physician, scientist, educator, and humanitarian. Gastroenterology (2011) 1.39
Genetic ablation of M3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia. Cancer Res (2008) 1.29
GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. PLoS One (2011) 1.26
Risk factors for primary hepatocellular carcinoma in black and white Americans in 2000. Clin Gastroenterol Hepatol (2006) 1.25
A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection. Proc Natl Acad Sci U S A (2007) 1.24
Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology (2010) 1.23
Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. Gastroenterology (2010) 1.20
Epstein-Barr virus induced hepatitis: An important cause of cholestasis. Hepatol Res (2005) 1.20
Leptin induces increased alpha2(I) collagen gene expression in cultured rat hepatic stellate cells. J Cell Biochem (2003) 1.19
Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet. Am J Physiol Gastrointest Liver Physiol (2011) 1.19
Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation. Am J Physiol Gastrointest Liver Physiol (2008) 1.19
The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. Prostate (2004) 1.15
Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C. Hepatology (2011) 1.13
Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism. Mol Endocrinol (2006) 1.09
Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C. Neurosci Lett (2004) 1.07
Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3). J Cell Biochem (2010) 1.07
Murine alanine aminotransferase: cDNA cloning, functional expression, and differential gene regulation in mouse fatty liver. Hepatology (2004) 1.06
Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus. Environ Health Perspect (2003) 1.05
Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy. Clin Gastroenterol Hepatol (2005) 1.02
Xanthogranulomatous pyelonephritis in a renal allograft associated with xanthogranulomatous diverticulitis: report of the first case and review of the literature. Nephrol Dial Transplant (2007) 1.00
Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis. Biochem J (2011) 0.99
Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression. Int J Cancer (2004) 0.97
Population pharmacokinetics and pharmacodynamics of ribavirin in patients with chronic hepatitis C genotype 1 infection. AAPS J (2012) 0.93
Histologic findings in lung biopsies in patients with suspected graft-versus-host disease. Hum Pathol (2013) 0.93
Cholinergic agonist-induced pepsinogen secretion from murine gastric chief cells is mediated by M1 and M3 muscarinic receptors. Am J Physiol Gastrointest Liver Physiol (2005) 0.91
Antagonistic interaction between Wnt and Notch activity modulates the regenerative capacity of a zebrafish fibrotic liver model. Hepatology (2014) 0.90
Survival prediction and gene identification with penalized global AUC maximization. J Comput Biol (2009) 0.90
The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA). Dig Dis Sci (2013) 0.88
BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression. Transplantation (2004) 0.88
Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis. Am J Med (2002) 0.87
Cholinergic muscarinic receptor activation augments murine intestinal epithelial cell proliferation and tumorigenesis. BMC Cancer (2013) 0.87
Rare presentation of unicentric Castleman's disease in the parotid gland. J Oral Maxillofac Surg (2012) 0.87
Optimum ribavirin exposure overcomes racial disparity in efficacy of peginterferon and ribavirin treatment for hepatitis C genotype 1. Am J Gastroenterol (2012) 0.85
Cholesterol embolization syndrome induced by thrombolytic therapy. Am J Cardiovasc Drugs (2008) 0.85
Scopolamine treatment and muscarinic receptor subtype-3 gene ablation augment azoxymethane-induced murine liver injury. J Pharmacol Exp Ther (2010) 0.84
Actin nemaline myopathy mouse reproduces disease, suggests other actin disease phenotypes and provides cautionary note on muscle transgene expression. PLoS One (2011) 0.84
Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease. J Fam Pract (2010) 0.84
Quantitation of T lymphocytes in posttransplant transbronchial biopsies. Hum Pathol (2009) 0.83
The role of gastrointestinal hormones in hepatic lipid metabolism. Semin Liver Dis (2013) 0.83
Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipients. Transplantation (2008) 0.83
IL28B genotype does not correlate with HIV control in African Americans. Clin Transl Sci (2011) 0.82
Peripheral blood gene expression profile associated with sustained virologic response after peginterferon plus ribavirin therapy for chronic hepatitis-C genotype 1. J Natl Med Assoc (2008) 0.81
Hyperbaric oxygen treatment for intractable diarrhea caused by pneumatosis coli. Gastrointest Endosc (2002) 0.81
Superficial CD34-positive fibroblastic tumour: report of two new cases. Pathology (2015) 0.81
Increased macrophage density of cardiac allograft biopsies is associated with antibody-mediated rejection and alloantibodies to HLA antigens. Clin Transplant (2014) 0.80
Dialysis reduces portal pressure in patients with chronic hepatitis C. Artif Organs (2010) 0.79
Liver allograft outcomes after laparoscopic-assisted and minimal access live donor hepatectomy for transplantation. Am J Surg (2011) 0.79
Acute renal failure and nephrotic range proteinuria due to amyloidosis in an HIV-infected patient. Am J Med Sci (2006) 0.78
Evolution of midurethral and other mesh slings--a critical analysis. Neurourol Urodyn (2012) 0.78
Racial disparities in liver transplantation for hepatitis B: to be or not to be. Liver Transpl (2009) 0.78
Fatal granulomatous bronchopneumonia complicated by acute renal failure. South Med J (2002) 0.78
Glial cell line-derived neurotrophic factor protects against high-fat diet-induced obesity. Am J Physiol Gastrointest Liver Physiol (2014) 0.78
Treatment of fibrosis in nonalcoholic fatty liver disease. Curr Gastroenterol Rep (2007) 0.78
The hepatitis C crisis in the African American Community: findings and recommendations. J Natl Med Assoc (2013) 0.78
Colonic cystic lymphangioma. Gastrointest Endosc (2004) 0.78
Adjuvant systemic therapy protocol for Dukes' B2 and C resectable colon carcinoma. Tumori (2002) 0.77
Chlorzoxazone as a cause of acute liver failure requiring liver transplantation. Dig Dis Sci (2007) 0.77
Adiponectin and alcoholic fatty liver: Is it, after all, about what you eat? Hepatology (2005) 0.77
The efficacy of real-time 3-dimensional echocardiography for right ventricular biopsy. J Am Soc Echocardiogr (2005) 0.76
Full thickness transanal re-excision following endoscopic removal of malignant rectal polyps. Int J Colorectal Dis (2009) 0.75
The Diabetes Prevention Program and the metabolic syndrome. Ann Intern Med (2005) 0.75
Connecting the dots from fatty acids to nonalcoholic steatohepatitis: epigenetics in the spotlight. Hepatology (2013) 0.75
Increased liver enzyme levels and HNF-1beta gene mutation. Clin Gastroenterol Hepatol (2008) 0.75
Reply to: "Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling". J Hepatol (2012) 0.75
Fatal persistence of West Nile virus subtype Kunjin in the brains of flavivirus resistant mice. Virus Res (2010) 0.75
Endothelitis in cardiac allograft biopsy specimens: possible relationship to antibody-mediated rejection. J Heart Lung Transplant (2010) 0.75
No proof HIV antibodies are caused by a retroviral infection. Emerg Med Australas (2006) 0.75
Rescue therapy for acute antibody mediated rejection with a proteosome inhibitor after kidney transplantation. Clin Transpl (2010) 0.75
Oligoclonal expansion of T cell receptor V beta 2 and 3 cells in the livers of mice with graft-versus-host disease. Hepatology (2002) 0.75
Hepatorenal syndrome. Definition, pathophysiology, and intervention. Crit Care Clin (2002) 0.75
A critique of the Montagnier evidence for the HIV/AIDS hypothesis. Med Hypotheses (2004) 0.75
Antibody-mediated rejection of renal allograft in combined liver-kidney transplant. Clin Transplant (2010) 0.75
Intimal IgM lambda paraprotein deposition in myocardial arteries resulting in acute myocardial infarction and sudden death. Pathology (2011) 0.75
Electronic clinical challenges and images in GI. Fibrolamellar carcinoma. Gastroenterology (2007) 0.75
Polyomavirus nephropathy. Saudi J Kidney Dis Transpl (2008) 0.75